SCHEMBL6444265

SCHEMBL6444265

CNC(=O)Oc1nc(-c2ccc(F)c3c(C(=O)C(=O)N4CCN(C(=O)c5ccccc5)CC4)c[nH]c23)no1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 6/20 0.47
CYP3A4 P08684 3/20 0.44
CYP2C19 P33261 6/20 0.42
CYP2D6 P10635 5/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C8 P10632 1/20 0.42
CYP2B6 P20813 1/20 0.42
KCNH2 Q12809 1/20 0.42
S1PR1 P21453 2/20 0.33
BTK Q06187 1/20 0.33
TSHR P16473 2/20 0.33
HDAC4 P56524 1/20 0.33
KIT P10721 1/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MAPT P10636 1/20 0.33
HRH3 Q9Y5N1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6446746 0.91 CYP2C9 (0.48) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6441405 0.90 CYP2C9 (0.54) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6443694 0.87 CYP2C9 (0.49) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6445461 0.86 CYP2C9 (0.48) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6442373 0.86 CYP2C9 (0.49) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6442400 0.86 CYP2C9 (0.51) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6445443 0.85 CYP2C9 (0.50) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6446764 0.85 CYP2C9 (0.45) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6471975 0.84 CYP2C9 (0.48) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2
SCHEMBL6441228 0.84 CYP2C9 (0.46) CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299382-B1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED INDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2005-09-21 EP claimed